Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
The Netherlands Cancer Institute
Charite University, Berlin, Germany
Canadian Cancer Trials Group
University Hospital Tuebingen
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
INSYS Therapeutics Inc